| 1. |
張哲,劉巨平,劉竹青,等. 高糖狀態下視網膜血管內皮細胞基因表達譜的RNA-Seq分析[J].中華眼底病雜志, 2018, 34(4): 377-381. DOI: 10.3760/cma.j.issn.1005-1015.2018.04.014.Zhang Z,Liu JP,Liu ZQ,et al. RNA-Seq analysis of gene expression profiling in retinal vascular endothelial cells under high glucose condition[J]. Chin J Ocul Fundus Dis, 2018, 34(4): 377-381. DOI: 10.3760/cma.j.issn.1005-1015.2018.04.014.
|
| 2. |
牛瑞,馬騰,杜雪利,等.抗血管內皮生長因子藥物治療后視網膜血管內皮細胞基因表達譜的RNA-Seq分析[J]. 中華眼底病雜志, 2018, 34(3): 275-280. DOI: 10.3760/cma.j.issn.1005-1015.2018.03.016.Niu R,Ma T,Du XL,et al. RNA-Seq analysis of gene expression profiling in human retinal vascular endothelial cells after anti-vascular endothecial growth factor treatment[J]. Chin J Ocul Fundus Dis, 2018, 34(3): 275-280. DOI: 10.3760/cma.j.issn.1005-1015.2018.03.016.
|
| 3. |
Trzybulska D, Vergadi E, Tsatsanis C. miRNA and other non-coding RNA as promising diagnostic markers[J]. EJIFCC, 2018, 29(3): 221-226.
|
| 4. |
Chen N, Wang J, Hu Y, et al.MicroRNA-410 reduces the expression of vascular endothelial growth factor and inhibits oxygen-induced retinal neovascularization[J/OL].PLoS One, 2014, 9(4): 95665[2014-04-28].https://doi.org/10.1371/journal.pone.0095665. DOI:10.1371/journal.pone.0095665.
|
| 5. |
Shen J, Yang X, Xie B, et al. MicroRNAs regulate ocular neovascularization[J]. Mol Ther, 2008, 16(7): 1208-1216. DOI: 10.1038/mt.2008.104.
|
| 6. |
Han S, Kong YC, Sun B, et al. microRNA-218 inhibits oxygen-induced retinal neovascularization via reducing the expression of roundabout 1[J]. Chin Med J (Engl), 2016, 129(6): 709-715. DOI: 10.4103/0366-6999.178013.
|
| 7. |
Nagpal N, Kulshreshtha R. miR-191: an emerging player in disease biology[J]. Front Genet, 2014, 5: 99. DOI: 10.3389/fgene.2014.00099.
|
| 8. |
Gu Y, Ampofo E, Menger MD, et al. miR-191 suppresses angiogenesis by activation of NF-κB signaling[J]. FASEB J, 2017, 31(8): 3321-3333. DOI: 10.1096/fj.201601263R.
|
| 9. |
Smith LEH, Wesoloiuski E, Mclellan A, et al. Oxygen-induced retinopath in the mouse[J]. Invest Ophthalmol Vis Sci, 1994, 35: 101-111.
|
| 10. |
谷中秀, 姜靜, 黃敏, 等. 不同批次的重組誘餌型受體創新藥物RC28-E1與RC28-E2對視網膜新生血管的藥效學比較及機制[J]. 中華實驗眼科雜志, 2018, 36(8): 581-589. DOI: 10.3760/cma.j.issn.2095-0160.2018.08.002.Gu ZX, Jiang J, Huang M, et al. Comparison of pharmacodynamics between different batches of recombinant decoy receptor innovative drug RC28-E1 and RC28-E2 in retinal angiogenesis and neovascularization and its mechanism[J]. Chin J Exp Ophthalmol, 2018, 36(8): 581-589. DOI: 10.3760/cma.j.issn.2095-0160.2018.08.002.
|
| 11. |
He H, Liu R, Xiong W, et al. Lentiviral vector-mediated down-regulation of Notch1 in endometrial stem cells results in proliferation and migration in endometriosis[J]. Mol Cell Endocrinol, 2016, 434: 210-218. DOI: 10.1016/j.mce.2016.07.004.
|
| 12. |
Min X, Zhou Q, Dong X, et al. Expression profile and regulation of telomerase reverse transcriptase on oxygen-induced retinal neovascularization[J]. Curr Eye Res, 2011, 36(2): 135-142. DOI: 10.3109/02713683.2010.525679.
|
| 13. |
Liu CH, Sun Y, Li J, et al. Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization[J]. Proc Natl Acad Sci USA, 2015, 112(39): 12163-12168. DOI: 10.1073/pnas.1508426112.
|
| 14. |
Wang P, Luo Y, Duan H, et al. MicroRNA 329 suppresses angiogenesis by targeting CD146[J]. Mol Cell Biol, 2013, 33(18): 3689-3699. DOI: 10.1128/MCB.00343-13.
|
| 15. |
Colamaio M, Borbone E, Russo L, et al. miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting[J]. J Clin Endocrinol Metab, 2011, 96(12): 1915-1924. DOI: 10.1210/jc.2011-0408.
|
| 16. |
Kim JH, Lee BJ, Kim JH, et al. Rosmarinic acid suppresses retinal neovascularization via cell cycle arrest with increase of p21(WAF1) expression[J]. Eur J Pharmacol, 2009, 615(1-3): 150-154. DOI: 10.1016/j.ejphar.2009.05.015.
|
| 17. |
Han J, Li N. Adenoviral vector-mediated delivery of p21WAF1/CIP1 prevents retinal neovascularization in an oxygen-induced retinopathy model[J]. Curr Eye Res, 2016, 41(8): 1113-1117. DOI: 10.3109/02713683.2015.1090002.
|